SLC11A1 (formerly NRAMP1) and disease resistance.
Blackwell
J M
JM
Cambridge Institute for Medical Research, University of Cambridge School of Clinical Medicine, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2XY, UK. jmb37@cus.cam.ac.uk
Goswami
T
T
Evans
C A
CA
Sibthorpe
D
D
Papo
N
N
White
J K
JK
Searle
S
S
Miller
E N
EN
Peacock
C S
CS
Mohammed
H
H
Ibrahim
M
M
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001424:Bacterial Infections / Q000276:immunology*; D001692:Biological Transport; D002352:Carrier Proteins / Q000378:metabolism; D027682:Cation Transport Proteins / Q000378:metabolism / Q000502:physiology*; D002413:Cations, Divalent; D003141:Communicable Diseases; D000073840:Copper-Transporting ATPases; D004198:Disease Susceptibility; D019143:Evolution, Molecular; D006801:Humans; D007113:Immunity, Innate; D008264:Macrophages / Q000378:metabolism; D011110:Polymorphism, Genetic; D011522:Protons; D011993:Recombinant Fusion Proteins; D013329:Structure-Activity Relationship; D014018:Tissue Distribution; D000099173:Natural Resistance-associated Macrophage Protein 1
D000251:Adenosine Triphosphatases; D002352:Carrier Proteins; D027682:Cation Transport Proteins; D002413:Cations, Divalent; D000073840:Copper-Transporting ATPases; D011522:Protons; D011993:Recombinant Fusion Proteins; D000099173:Natural Resistance-associated Macrophage Protein 1; C081184:ATP7A protein, human